Skip to main content
OpenTrials

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

49 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Enrolling by invitation

A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)

NCT05768386

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Cardiovascular Diseases, +9 more
Locations
  • Orthopedic Institute for Children, Orthopedic Hemophilia Treatment Center Los Angeles, California, United States
  • UC Davis Hemophilia Treatment Center Sacramento, California, United States
  • University of California San Diego, Hemophilia & Thrombosis Treatment Center San Diego, California, United States
  • University of California San Francisco - Moffit Hospital, Outpatient Hematology Clinic San Francisco, California, United States
View all 41 locations
View Trial Details
Active, not recruiting

A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A in Taiwan

NCT06684314

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +12 more
Locations
  • Investigational Site Number : 1580008 Changhua, Taiwan
  • Investigational Site Number : 1580001 Taipei, Taiwan
  • Investigational Site Number : 1580002 Taipei, Taiwan
  • Investigational Site Number : 1580009 Kaohsiung City, Taiwan
View Trial Details
Active, not recruiting

A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)

NCT03162536

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +41 more
Locations
  • Mayo Clinic Hospital ( Site 0140) Scottsdale, Arizona, United States
  • UCLA Hematology & Oncology ( Site 0017) Los Angeles, California, United States
  • Colorado Blood Cancer Institute ( Site 0225) Denver, Colorado, United States
  • University of Michigan ( Site 0018) Ann Arbor, Michigan, United States
View Trial Details
Active, not recruiting

A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis

NCT03165734

Conditions
Anemia, Blood Platelet Disorders, Bone Marrow Diseases, +11 more
Locations
  • University of Alabama at Birmingham, (UAB) Hospital, Comprehensive Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 207 locations
View Trial Details
Active, not recruiting

Phase 3 Study for Efficacy and Safety Outcomes Data in Japanese Patients With Severe Hemophilia A

NCT06224907

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Cardiovascular Diseases, +9 more
Locations
  • Asahikawa Medical University Hospital Hokkaido, Asahikawa, Japan
  • Saitama Medical University Hospital Saitama, Iruma-gun, Japan
  • Nagoya University Hospital Aichi, Nagoya, Japan
  • Tokyo Medical University Hospital Tokyo, Shinjuku-ku, Japan
View Trial Details
Completed

Safety, Tolerability, and Efficacy Study of Valoctocogene Roxaparvovec in Hemophilia A With Active or Prior Inhibitors

NCT04684940

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Cardiovascular Diseases, +11 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Hemocentro Da UNICAMP Campinas, Brazil
  • Chaim Sheba Medical Center Ramat Gan, Israel
  • Kyung Hee University Hospital at Gangdong Seoul, South Korea
View Trial Details
Completed

A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.

NCT05228470

Conditions
BCMA, BCMA-CD3 Bispecific, Bispecific, +23 more
Locations
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
  • Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
View all 15 locations
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of Valoctocogene Roxaparvovec, With Prophylactic Steroids in Hemophilia A

NCT04323098

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Cardiovascular Diseases, +9 more
Locations
  • University of California Davis Health Sacramento, California, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Nationwide Children's Hospital Columbus, Ohio, United States
  • The Royal Adelaide Hospital Adelaide, Australia
View Trial Details
Completed

An International Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B

NCT03901755

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Swedish Orphan Biovitrum Research Site Brno, Czechia
  • Swedish Orphan Biovitrum Research Site Prague, Czechia
  • Swedish Orphan Biovitrum Research Site (Haemophilia Center Aghia Sophia Children's Hospital) Athens, Greece
  • Swedish Orphan Biovitrum Research Site (Laikο General Hospital of Athens) Athens, Greece
View all 29 locations
View Trial Details

Related conditions